Literature DB >> 18427137

Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction.

Ankur Saxena1, Jason E Fish, Michael D White, Sangho Yu, James W P Smyth, Robin M Shaw, J Michael DiMaio, Deepak Srivastava.   

Abstract

BACKGROUND: Heart disease is a leading cause of mortality throughout the world. Tissue damage from vascular occlusive events results in the replacement of contractile myocardium by nonfunctional scar tissue. The potential of new technologies to regenerate damaged myocardium is significant, although cell-based therapies must overcome several technical barriers. One possible cell-independent alternative is the direct administration of small proteins to damaged myocardium. METHODS AND
RESULTS: Here we show that the secreted signaling protein stromal cell-derived factor-1alpha (SDF-1alpha), which activates the cell-survival factor protein kinase B (PKB/Akt) via the G protein-coupled receptor CXCR4, protected tissue after an acute ischemic event in mice and activated Akt within endothelial cells and myocytes of the heart. Significantly better cardiac function than in control mice was evident as early as 24 hours after infarction as well as at 3, 14, and 28 days after infarction. Prolonged survival of hypoxic myocardium was followed by an increase in levels of vascular endothelial growth factor protein and neoangiogenesis. Consistent with improved cardiac function, mice exposed to SDF-1alpha demonstrated significantly decreased scar formation than control mice.
CONCLUSIONS: These findings suggest that SDF-1alpha may serve a tissue-protective and regenerative role for solid organs suffering a hypoxic insult.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427137      PMCID: PMC2743260          DOI: 10.1161/CIRCULATIONAHA.107.694992

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  32 in total

1.  SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models.

Authors:  F Mirshahi; J Pourtau; H Li; M Muraine; V Trochon; E Legrand; J Vannier; J Soria; M Vasse; C Soria
Journal:  Thromb Res       Date:  2000-09-15       Impact factor: 3.944

2.  Intramyocardial injection of vascular endothelial growth factor gene improves cardiac performance and inhibits cardiomyocyte apoptosis.

Authors:  Yin Ruixing; Yang Dezhai; Wu Hai; Huang Kai; Wu Xianghong; Chen Yuming
Journal:  Eur J Heart Fail       Date:  2007-01-23       Impact factor: 15.534

3.  Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells.

Authors:  A Corcione; L Ottonello; G Tortolina; P Facchetti; I Airoldi; R Guglielmino; P Dadati; M Truini; S Sozzani; F Dallegri; V Pistoia
Journal:  J Natl Cancer Inst       Date:  2000-04-19       Impact factor: 13.506

4.  Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation.

Authors:  Carola Porcile; Adriana Bajetto; Federica Barbieri; Simone Barbero; Rudy Bonavia; Marianna Biglieri; Paolo Pirani; Tullio Florio; Gennaro Schettini
Journal:  Exp Cell Res       Date:  2005-08-15       Impact factor: 3.905

5.  Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Authors:  Akira Orimo; Piyush B Gupta; Dennis C Sgroi; Fernando Arenzana-Seisdedos; Thierry Delaunay; Rizwan Naeem; Vincent J Carey; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

6.  Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

Authors:  Angela Kortesidis; Andrew Zannettino; Sandra Isenmann; Songtao Shi; Tsvee Lapidot; Stan Gronthos
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

7.  Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement.

Authors:  Massimiliano Gnecchi; Huamei He; Nicolas Noiseux; Olin D Liang; Lunan Zhang; Fulvio Morello; Hui Mu; Luis G Melo; Richard E Pratt; Joanne S Ingwall; Victor J Dzau
Journal:  FASEB J       Date:  2006-04       Impact factor: 5.191

8.  Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis.

Authors:  Eric Ackah; Jun Yu; Stefan Zoellner; Yasuko Iwakiri; Carsten Skurk; Rei Shibata; Noriyuki Ouchi; Rachael M Easton; Gennaro Galasso; Morris J Birnbaum; Kenneth Walsh; William C Sessa
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

9.  Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stress.

Authors:  Kanu Chatterjee; Jianqing Zhang; Norman Honbo; Uschi Simonis; Robin Shaw; Joel S Karliner
Journal:  J Mol Cell Cardiol       Date:  2007-06-21       Impact factor: 5.000

10.  Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs.

Authors:  Matteo Ferrarini; Nikola Arsic; Fabio A Recchia; Lorena Zentilin; Serena Zacchigna; Xiaobin Xu; Axel Linke; Mauro Giacca; Thomas H Hintze
Journal:  Circ Res       Date:  2006-03-16       Impact factor: 17.367

View more
  96 in total

1.  CXCR4 gene transfer prevents pressure overload induced heart failure.

Authors:  Thomas J Larocca; Dongtak Jeong; Erik Kohlbrenner; Ahyoung Lee; Jiqiu Chen; Roger J Hajjar; Sima T Tarzami
Journal:  J Mol Cell Cardiol       Date:  2012-06-03       Impact factor: 5.000

2.  SDF-1α and CXCR4 as therapeutic targets in cardiovascular disease.

Authors:  Jessica Wen; Jian-Qing Zhang; Wei Huang; Yigang Wang
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

Review 3.  Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure.

Authors:  Vincenzo Lionetti; Giacomo Bianchi; Fabio A Recchia; Carlo Ventura
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

4.  β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4.

Authors:  Thomas J LaRocca; Martina Schwarzkopf; Perry Altman; Shihong Zhang; Achla Gupta; Ivone Gomes; Zikiar Alvin; Hunter C Champion; Georges Haddad; Roger J Hajjar; Lakshmi A Devi; Alison D Schecter; Sima T Tarzami
Journal:  J Cardiovasc Pharmacol       Date:  2010-11       Impact factor: 3.105

5.  Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.

Authors:  Joshua J Ziarek; Anthony E Getschman; Stephen J Butler; Deni Taleski; Bryan Stephens; Irina Kufareva; Tracy M Handel; Richard J Payne; Brian F Volkman
Journal:  ACS Chem Biol       Date:  2013-06-26       Impact factor: 5.100

6.  Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling.

Authors:  Tiemin Zhao; Dongsheng Zhang; Ronald W Millard; Muhammad Ashraf; Yigang Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

7.  Myocardial Ischemia Induces SDF-1α Release in Cardiac Surgery Patients.

Authors:  Bong-Sung Kim; Denise Jacobs; Christoph Emontzpohl; Andreas Goetzenich; Josefin Soppert; Mareike Jarchow; Lisa Schindler; Luisa Averdunk; Sandra Kraemer; Gernot Marx; Jürgen Bernhagen; Norbert Pallua; Heinz-Peter Schlemmer; David Simons; Christian Stoppe
Journal:  J Cardiovasc Transl Res       Date:  2016-04-07       Impact factor: 4.132

Review 8.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

9.  G-CSF enhanced SDF-1 gradient between bone marrow and liver associated with mobilization of peripheral blood CD34+ cells in rats with acute liver failure.

Authors:  Yan Lei; Zhengwen Liu; Qunying Han; Wen Kang; Lei Zhang; Sai Lou
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

10.  Myocardial delivery of stromal cell-derived factor 1 in patients with ischemic heart disease: safe and promising.

Authors:  Roger J Hajjar; Jean-Sebastien Hulot
Journal:  Circ Res       Date:  2013-02-21       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.